Skip to content
23-M, Gulberg III, Lahore(92-42) 37339087-89
Neutro PharmaResearch & Development

Frommoleculeto market.WHO-GMP · ICH

Our R&D teams develop and optimise medicines for safety, efficacy and affordability, in laboratories built to WHO-GMP and ICH standards.

Researcher examining a flask in the laboratoryFormulation · Analytical · Regulatory
Process

Five stages,
one team.

Led by PhDs, pharmacists and formulation chemists.

01

Formulation development

Formulation labs design and optimise each dosage form.

02

Analytical R&D

HPLC, FTIR, UV and dissolution testing, with stability chambers.

03

Pilot scale-up

An in-house pilot plant for scale-up and process validation.

04

Clinical coordination

Bioequivalence studies with partner CROs.

05

Regulatory affairs

Dossiers in CTD and eCTD formats for DRAP and export markets.

Therapeutic focus

Where weare investing.

Research priorities follow market needs and public health trends.

  • Oncology

    Focus 01
  • Cardiovascular

    Focus 02
  • Neurology & psychiatry

    Focus 03
  • Infectious diseases

    Focus 04
  • Dermatology & cosmetology

    Focus 05
  • Orthopedics & rheumatology

    Focus 06
  • Nutraceuticals

    Focus 07

// Partnerships

We work with CROs, formulators and universities across MENA, Southeast Asia and Africa on bioequivalence studies and technology transfer.

Export-ready dossiers
  • United Arab Emirates
  • Iraq
  • Sri Lanka
  • African markets
Protocols followed
  • DRAP
  • WHO
  • ICH
  • EU
Scientist pipetting samples into a plate
The team

Five disciplines under one roof.

Led by PhDs, pharmacists and formulation chemists with decades of combined experience.

Formulation Development, Analytical R&D, Microbiology, Clinical Trial Coordination and Regulatory Affairs.

Propose a collaboration

Let'stalk.

Export partnerships 30+markets Product enquiries Audits & visits
Gulberg III23-M, Gulberg III, Lahore, Pakistan